Antimanic‐like effect of dipyridamole in the methylphenidate‐induced hyperlocomotion
Fundamental & Clinical Pharmacology · 2024
DOI: 10.1111/fcp.13001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, 2024. Verfasst von Anderson Gustavo Santos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Physiology and Pharmacology of the Central Nervous System, Department of Pharmacology, Federal University of Paraná, Centro Politécnico…. Hauptthemen laut MEDLINE: Dipyridamole, Methylphenidate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Background
Adenosinergic system has been implicated in the pathophysiology of bipolar disorder and drugs that affect adenosine neurotransmission have shown some efficacy as add‐on therapy in manic patients.
Objective
Thus, the aim of the present study was to screen adenosinergic drugs for antimanic‐like effect in methylphenidate (MPH)‐induced hyperlocomotion in mice.
Methods
Male and female Swiss mice received a single allopurinol (50 and 200 mg/kg, ip), dipyridamole (20 mg/kg, ip), or inosine (50 mg/kg, ip) administration before an acute MPH challenge (5 mg/kg, sc). In experiments with repeated treatment, male mice received a daily administration of allopurinol (25 and 50 mg/kg, ip), dipyridamole (20 mg/kg, ip), or inosine (50 mg/kg, ip) for 14 days. Finally, pretreatment with aminophylline (2 mg/kg, sc), an unspecific adenosine receptor antagonist, was used to evaluate a putative adenosinergic mediation. Locomotor activity was measured in the automated activity chamber for 20 min.
Results
Acute and repeated dipyridamole reduced the increase in locomotor activity induced by MPH, while allopurinol and inosine had no effect. Aminophylline blocked the effect of dipyridamole in MPH‐induced hyperlocomotion.
Conclusion
The present results suggest that dipyridamole may have an antimanic‐like effect through adenosine receptors and reinforce the proposal that the adenosine system may be an interesting target for new antimanic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Physiology and Pharmacology of the Central Nervous System, Department of Pharmacology, Federal University of Paraná, Centro Politécnico, Curitiba, PR, Brazil.
ORCID-Profile: Roberto Andreatini
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Santos, A. G., Kühl, C. E., Higashijima, A. N., Kanazawa, L. K. S., de Souza, S. T. F., & Andreatini, R. (2024). Antimanic‐like effect of dipyridamole in the methylphenidate‐induced hyperlocomotion. Fundamental & Clinical Pharmacology. https://doi.org/10.1111/fcp.13001
Vancouver
Santos AG, Kühl CE, Higashijima AN, Kanazawa LKS, de Souza STF, Andreatini R. Antimanic‐like effect of dipyridamole in the methylphenidate‐induced hyperlocomotion. Fundamental & Clinical Pharmacology. 2024. doi:10.1111/fcp.13001
BibTeX
@article{Santos2024,
author = {Santos, Anderson Gustavo and Kühl, Carlos Eduardo and Higashijima, Arisa Namie and Kanazawa, Luiz Kae Sales and de Souza, Suzen Tortato Furtado and Andreatini, Roberto},
title = {Antimanic‐like effect of dipyridamole in the methylphenidate‐induced hyperlocomotion},
journal = {Fundamental & Clinical Pharmacology},
year = {2024},
doi = {10.1111/fcp.13001}
}
EUVIMED